Sol-Gel Technologies (SLGL) Competitors $14.61 +1.17 (+8.71%) Closing price 08/7/2025 04:00 PM EasternExtended Trading$14.02 -0.59 (-4.07%) As of 09:07 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock SLGL vs. CHEK, DRCT, MOLN, NVCT, GNLX, CGEN, KRRO, SPRO, BHST, and FATEShould you be buying Sol-Gel Technologies stock or one of its competitors? The main competitors of Sol-Gel Technologies include Check-Cap (CHEK), Direct Digital (DRCT), Molecular Partners (MOLN), Nuvectis Pharma (NVCT), Genelux (GNLX), Compugen (CGEN), Korro Bio (KRRO), Spero Therapeutics (SPRO), BioHarvest Sciences (BHST), and Fate Therapeutics (FATE). Sol-Gel Technologies vs. Its Competitors Check-Cap Direct Digital Molecular Partners Nuvectis Pharma Genelux Compugen Korro Bio Spero Therapeutics BioHarvest Sciences Fate Therapeutics Check-Cap (NASDAQ:CHEK) and Sol-Gel Technologies (NASDAQ:SLGL) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, risk, institutional ownership, earnings, dividends, analyst recommendations, valuation and media sentiment. Which has higher valuation and earnings, CHEK or SLGL? Sol-Gel Technologies has higher revenue and earnings than Check-Cap. Sol-Gel Technologies is trading at a lower price-to-earnings ratio than Check-Cap, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCheck-CapN/AN/A-$17.57M-$3.00-0.21Sol-Gel Technologies$11.54M3.53-$10.58M-$4.70-3.11 Does the media favor CHEK or SLGL? In the previous week, Check-Cap's average media sentiment score of 0.00 equaled Sol-Gel Technologies'average media sentiment score. Company Overall Sentiment Check-Cap Neutral Sol-Gel Technologies Neutral Which has more risk & volatility, CHEK or SLGL? Check-Cap has a beta of 0.19, meaning that its stock price is 81% less volatile than the S&P 500. Comparatively, Sol-Gel Technologies has a beta of 1.21, meaning that its stock price is 21% more volatile than the S&P 500. Do insiders & institutionals believe in CHEK or SLGL? 1.1% of Check-Cap shares are held by institutional investors. Comparatively, 26.2% of Sol-Gel Technologies shares are held by institutional investors. 0.5% of Check-Cap shares are held by company insiders. Comparatively, 66.5% of Sol-Gel Technologies shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Is CHEK or SLGL more profitable? Check-Cap has a net margin of 0.00% compared to Sol-Gel Technologies' net margin of -107.78%. Check-Cap's return on equity of 0.00% beat Sol-Gel Technologies' return on equity.Company Net Margins Return on Equity Return on Assets Check-CapN/A N/A N/A Sol-Gel Technologies -107.78%-43.98%-35.28% Do analysts recommend CHEK or SLGL? Sol-Gel Technologies has a consensus target price of $40.00, indicating a potential upside of 173.79%. Given Sol-Gel Technologies' stronger consensus rating and higher possible upside, analysts clearly believe Sol-Gel Technologies is more favorable than Check-Cap.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Check-Cap 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Sol-Gel Technologies 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 SummarySol-Gel Technologies beats Check-Cap on 8 of the 13 factors compared between the two stocks. Get Sol-Gel Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for SLGL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SLGL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SLGL vs. The Competition Export to ExcelMetricSol-Gel TechnologiesMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$37.44M$3.73B$5.42B$9.56BDividend YieldN/A1.27%3.99%4.14%P/E Ratio-3.119.6329.9025.14Price / Sales3.5312.03372.1776.15Price / CashN/A6.4235.9458.58Price / Book1.414.028.105.59Net Income-$10.58M-$109.62M$3.26B$265.48M7 Day Performance12.38%4.29%0.65%1.22%1 Month Performance108.42%17.15%2.43%0.39%1 Year Performance290.12%34.11%27.70%23.47% Sol-Gel Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SLGLSol-Gel Technologies1.8024 of 5 stars$14.61+8.7%$40.00+173.8%+290.1%$37.44M$11.54M-3.1150Upcoming EarningsCHEKCheck-CapN/A$0.65-3.9%N/A-68.1%$3.96MN/A-0.2280DRCTDirect Digital2.9334 of 5 stars$0.59+17.7%$6.00+913.3%-86.7%$9.51M$48.17M-0.3460Earnings ReportGap UpHigh Trading VolumeMOLNMolecular Partners2.1626 of 5 stars$3.73+5.5%$12.00+222.1%-40.1%$142.52M$2.23M-1.94180Gap UpNVCTNuvectis Pharma2.5107 of 5 stars$7.29+7.2%$15.33+110.3%-7.1%$142.08MN/A-6.458Earnings ReportAnalyst RevisionGap UpGNLXGenelux1.1478 of 5 stars$3.51flat$17.75+405.7%+73.1%$132.54M$10K-3.9910News CoverageEarnings ReportUpcoming EarningsGap UpCGENCompugen1.6637 of 5 stars$1.46-1.4%$4.00+174.0%-11.7%$132.07M$27.86M-9.1370News CoverageEarnings ReportKRROKorro Bio1.4388 of 5 stars$15.49+11.8%$102.43+561.3%-55.4%$130.06M$2.27M-1.6470Upcoming EarningsGap UpSPROSpero Therapeutics3.861 of 5 stars$2.26-1.7%$5.00+121.2%+76.4%$128.59M$47.98M-1.77150BHSTBioHarvest SciencesN/A$7.67-0.3%$13.67+78.2%N/A$126.28M$27.70M-15.34N/ANews CoverageUpcoming EarningsFATEFate Therapeutics3.987 of 5 stars$1.06-0.9%$3.83+261.6%-75.4%$122.63M$13.63M-0.71550Upcoming Earnings Related Companies and Tools Related Companies Check-Cap Alternatives Direct Digital Alternatives Molecular Partners Alternatives Nuvectis Pharma Alternatives Genelux Alternatives Compugen Alternatives Korro Bio Alternatives Spero Therapeutics Alternatives BioHarvest Sciences Alternatives Fate Therapeutics Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SLGL) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAltucher: Trump’s Great Gain is startingNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredCritical AI announcement set to ignite AI 2.0 A new 100% tariff on imported chips just rattled the tech sector—sending some stocks soaring and others tumbli...Timothy Sykes | SponsoredTrump’s new nightmareAccording to Porter Stansberry and Jeff Brown, a government-led financial mobilization is already reshaping Am...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sol-Gel Technologies Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sol-Gel Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
